Reciprocal repression between Isl1 and Nkx2-5 defines the zebrafish embryonic cardiac pacemaker domain

Q: What is the clinical evidence from this study?

Population: Embryonic cardiac pacemaker development and bradyarrhythmia. Intervention: CRISPR/Cas9 genetic disruption of isl1, nkx2-5, and shox2 vs. Wild-type sibling zebrafish embryos. Primary outcome: Maintenance of pacemaker identity (Nkx2-5-negative venous pole domain and regular action potential initiation).

Q: What does this research mean for the field?

Isl1 maintains zebrafish cardiac pacemaker identity by repressing Nkx2-5 independently of Shox2, and loss of Isl1 induces chamber-like myocardial identity causing bradyarrhythmia that is rescued by reducing Nkx2-5 activity. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

Federico Tessadori; Laurence Garric; Lysander Blankenborg; Anjelie Kisoensingh; Rahul Rao Padala; Teun P. de Boer; Jeroen Bakkers

doi:10.64898/2026.10.16.759628

October 19, 2026Open Access

Reciprocal repression between Isl1 and Nkx2-5 defines the zebrafish embryonic cardiac pacemaker domain

View Full Paper

Ask AI

Bookmark

Share

Key result

Isl1 loss halves the pacemaker domain and causes bradyarrhythmia, rescued by Nkx2-5 suppression.

Why the study?

Although the gene regulatory network controlling cardiac pacemaker development has been extensively studied in mammals, whether the same regulatory hierarchy governs pacemaker development in other vertebrates remained unclear.

Does genetic disruption of Isl1, Nkx2-5, and Shox2 alter embryonic cardiac pacemaker identity and electrophysiological function in zebrafish embryos?

Key Points

To define the gene regulatory network establishing and maintaining cardiac pacemaker identity in embryonic zebrafish.
Combined high-speed optical mapping with myocardial-specific FRET voltage sensor imaging and CRISPR/Cas9 genetic knockouts in zebrafish embryos.
Quantified cardiac action potential initiation, conduction intervals, and repolarization kinetics at 3 days post-fertilization in isl1 and tbx5a crispants.
Generated three independent mutant alleles of shox2 (shox2_RL, shox2_HD, and shox2_TR) and analyzed cardiac morphology and marker expression at 52 hours post-fertilization.
Isl1 deficiency caused venous pole cardiomyocytes to lose expression of bmp4, shox2, hcn4, and tbx2b, expand chamber marker nppa, and initiate action potentials ectopically throughout the atrium, leading to severe bradyarrhythmia.
Reducing Nkx2-5 activity largely restored regular cardiac rhythm despite persistent loss of other Isl1-dependent pacemaker markers.
Homozygous mutants across all three shox2 mutant alleles displayed heart rates indistinguishable from wild-type siblings at 5 days post-fertilization, with unaltered isl1 expression and normal venous pole specification.

Structured PICO

Does genetic disruption of Isl1, Nkx2-5, and Shox2 alter embryonic cardiac pacemaker identity and electrophysiological function in zebrafish embryos?

P

Population

Zebrafish embryos and larvae studied from 22 somites to 5 days post-fertilization using high-speed optical voltage mapping and CRISPR/Cas9 genetic perturbations.

I

Intervention

Genetic perturbation via CRISPR/Cas9-mediated F0 mutagenesis or mutant allele generation targeting isl1, tbx5a, shox2, and nkx2-5, as well as pharmacological inhibition of BMP signaling and suppression of tbx2b.

C

Comparator

Wild-type sibling zebrafish embryos and tbx5a-deficient embryos.

O

Outcome

Cardiac pacemaker identity and electrophysiological function (site of action potential initiation, propagation velocity, beat-to-beat variability in conduction intervals, and repolarization kinetics measured as APD50) assessed via high-speed optical voltage mapping at 3 days post fertilization (dpf) and whole mount in situ hybridization at 26 hpf, 52 hpf, and 5 dpf.surrogate

This preclinical study demonstrates that in zebrafish embryos, Isl1 maintains cardiac pacemaker identity and prevents bradyarrhythmia by directly restricting Nkx2-5 expression at the venous pole independently of Shox2, revealing an evolutionary divergence from the mammalian pacemaker gene regulatory network.

Limitations

Preclinical animal model (zebrafish embryos) with evolutionary divergence from mammalian sinoatrial node regulation.
Residual Shox2 activity cannot be formally excluded in the three generated shox2 mutant alleles.
Whether the reciprocal antagonism between Isl1 and Nkx2-5 involves direct transcriptional repression remains undetermined and requires future genomic and biochemical studies.
Cannot formally exclude residual Shox2 activity in the three independently generated shox2 mutant alleles analyzed.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Isl1-Nkx2-5 axis specifies pacemaker cells in zebrafish; extends mammalian gene networks but remains hypothesis-generating for human bradyarrhythmias.

Abstract

The cardiac pacemaker initiates each heartbeat and is essential for normal cardiac function. Although the gene regulatory network controlling pacemaker development has been extensively studied in mammals, it remains unclear whether the same regulatory hierarchy governs pacemaker development in other vertebrates. Here, we combined high-speed optical mapping with genetic analysis to define the gene regulatory network that establishes and maintains pacemaker identity in the zebrafish embryo. We show that the LIM-homeodomain transcription factor Isl1 is essential for maintaining pacemaker identity of venous pole cardiomyocytes. Loss of Isl1 causes pacemaker cells to acquire chamber-like characteristics through ectopic nkx2-5 expression, resulting in loss of a dominant pacemaker site and severe bradyarrhythmia. Reducing Nkx2-5 activity largely restores regular rhythm despite persistent loss of other Isl1-dependent markers, indicating that inappropriate Nkx2-5 activity contributes substantially to the electrophysiological defects in isl1 mutants. In contrast, genetic disruption of shox2 does not impair embryonic pacemaker development or alter isl1 expression, suggesting that Shox2 is not an essential component of the zebrafish pacemaker gene regulatory network. Together, our findings establish a zebrafish-specific transcriptional hierarchy in which Isl1 safeguards pacemaker identity by restricting Nkx2-5 independently of Shox2. These results show that a conserved boundary between pacemaker and chamber myocardium can be maintained by distinct upstream factors during vertebrate heart development.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tessadori et al. (2026) studied Embryonic cardiac pacemaker development and bradyarrhythmia. CRISPR/Cas9 genetic disruption of isl1, nkx2-5, and shox2 vs. Wild-type sibling zebrafish embryos was evaluated on Maintenance of pacemaker identity (Nkx2-5-negative venous pole domain and regular action potential initiation). Loss of Isl1 in zebrafish embryos halved the Nkx2-5-negative pacemaker domain (~15% of atrium in wild-type) causing bradyarrhythmia, while Nkx2-5 suppression restored regular rhythm.

synapsesocial.com/papers/6ae28e75cbadf70daf6c42b7 https://doi.org/10.64898/2026.10.16.759628

View Full Paper

Ask AI

Bookmark

Share

Reciprocal repression between Isl1 and Nkx2-5 defines the zebrafish embryonic cardiac pacemaker domain

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Reciprocal repression between Isl1 and Nkx2-5 defines the zebrafish embryonic cardiac pacemaker domain

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading